2018 Virtual Symposium (CME concluded): Identifying, Diagnosing and Managing Iron Deficiency in Patients with Heart Failure to Improve Outcomes and Quality of Life

Iron deficiency (ID) affects up to one-third of the world's population and is particularly common in elderly individuals and those with certain chronic diseases such as chronic kidney disease, and congestive heart failure. Many of those affected are unaware of ID and cannot recognize its symptoms. For patients with heart failure (HF), ID is an independent predictor of outcomes and a major contributor to exercise intolerance. At least half of all patients with HF have comorbid ID, yet the condition is under-recognized and untreated in most patients.

During this virtual symposium, experts will provide participants with data from recent and ongoing trials of iron repletion in patients with HF to highlight the importance of diagnosis and proper management of this common comorbidity. Recent updates to established HF treatment guidelines that emphasize ID recognition and treatment will also be addressed. Additionally, the program will educate clinicians on the differences in oral versus intravenous iron formulations.

Iron Deficiency in Heart Failure

Presenter: Gurusher S. Panjrath, MD, FACC, FAHA

Treatment of Anemia: Evidence from Recent and Ongoing Clinical Trials

Presenter: Akshay S. Desai, MD, MPH

Challenging Patient Case

Chairperson: Eldrin F. Lewis, MD, MPH

Presenter: Gurusher S. Panjrath, MD, FACC, FAHAAkshay S. Desai, MD, MPH

Audience Q&A

Panel: Eldrin F. Lewis, MD, MPHGurusher S. Panjrath, MD, FACC, FAHAAkshay S. Desai, MD, MPH